Full-Service Contract Research Organization (CRO)

aCROss Medical
We Deliver Results
Not Just Run Trials.

Because we've been on your side of the table.

Discuss Your Study Learn About Us
Clinical trial sites map across Georgia, Armenia, Israel and Uzbekistan Tbilisi HQ Yerevan Tel Aviv Tashkent
0+
Clinical Trials Completed
0+
Dedicated Clinical Centers
0+
Years Experience
0%
Study Success Rate
Peer-Reviewed. Independently Published.

Highlights From Our Work, In the World's Leading Journals.

Peer-reviewed publications representing just a portion of the trials we've led and delivered - including The Lancet and Ophthalmology journal, with aCROss team members named in the author list.

View Our Clinical Evidence →
Published In
Latest News aCROss Medical at LSI Europe '25 → Case Study: Exceeding Enrollment Targets in a Musculoskeletal Trial → All Articles →
Therapeutic Expertise

What We Cover

Med Devices
FIH - Pivotal
Pharma
Phase I - IV
Advanced Therapies
Cell & Gene (ATMP)
All Phases
Phase I - IV
Cardiology Ophthalmology Orthopaedics Neurology Urology
ATMPs OBGYN ICU General Surgery Infectious Disease Oncology Respiratory Vascular
Center of Excellence

aCROss Vision

With a significant track record across multiple ophthalmology subspecialties - from glaucoma to retina, cornea to ocular implants.

Learn More
aCROss Vision
The Challenge

Key Challenges in Clinical Trials

Regulatory delays, enrollment slowdowns, and high costs can lead to project standstill and significant budget overruns.

Lengthy Regulatory Timelines

US and EU regulatory approvals can take 6-8 months, delaying your study start and increasing time-to-market.

Slow Patient Enrollment

Overextended clinical staff and competitive site landscapes lead to slow enrollment across Western markets.

High Operational Costs

Rising study budgets in the US and Europe create significant financial pressure, especially for smaller sponsors.

The Solution

Why Choose Our Territories?

aCROss Medical offers a faster, more efficient alternative - run your clinical trial in our territories with us.

Benefit Georgia, Armenia, Israel & Uzbekistan Europe & US
Regulatory Process Fast approval (6-8 weeks) Lengthy approval
Research Teams Skilled & motivated clinical staff Experienced but often overextended
Enrollment Speed Fast enrollment across study sites Slow enrollment
Data Acceptance Accepted by EU & US agencies Accepted by EU & US agencies
Cost Efficiency Competitive study budgets High costs
Our Approach

What You Can Expect When You Work With Us

Choosing the right CRO is about more than capabilities - it's about the people you'll work with every day.

Direct Access

The people you meet at the start are the people you'll work with throughout your study.
Senior Leadership

Senior leaders don't disappear after the kickoff meeting. They stay involved from start to finish.
Responsive Communication

Clear communication. Timely answers. No unnecessary delays.
Practical Problem Solving

Focused on solutions, not obstacles.
Regional Expertise, Global Standards

Local knowledge backed by international expectations.
One Team

Your study becomes our shared mission.

We believe our partners shouldn't have to manage their CRO. They should be able to rely on one.

Read more about our approach
What Our Partners Say

Client Testimonials

Ophthalmology
BELKIN Vision collaborated with Across Medical on several projects, and the experience was consistently productive and efficient. The team was responsive, professional, and worked seamlessly on study, regulatory, site interactions and translations.
BV
Principal, Clinical Project Management
BELKIN Vision, Alcon Company
Cardiology
Evaluating Georgia for our clinical study was a strategic exercise that exceeded our expectations, thanks to the team at aCROss Medical. Yoram and Alio went far beyond standard CRO services, thoughtfully aligning clinical strategy with our long-term regulatory goals in Europe and the US.
AC
Senior Commercial & Clinical Advisor
AdjuCor GmbH
Orthopedics
aCROss Medical understood our challenges from day one. Their team didn't just manage the trial - they anticipated issues before they became problems. First site was initiated weeks ahead of schedule.
VP
VP Clinical Operations
US-based Biotech Company
Orthopedics
We partnered with aCROss Medical on a study that required a broad range of services, from site identification and feasibility through to patient recruitment, data management and ongoing monitoring activities. Most notably, they ensured we not only met but exceeded our ambitious targets for patient recruitment.
UK
Clinical Director
UK Medtech Company
Ophthalmology
At CorNeat Vision, we knew that taking our human feasibility study outside the U.S. would be a massive undertaking. We didn't just need a CRO; we needed a partner who knew the local landscape as well as we know our own technology. Across Medical was that partner.
GL
Gilad Litvin, MD
Founder & CMO, CorNeat Vision
Acute Ischemic Stroke
aCROss Medical built an operational infrastructure that addressed every challenge, from site qualification and hands-on procedural training to true 24/7 activation readiness. What initially seemed impossible on paper became a smoothly running trial.
BG
VP Preclinical & Clinical Affairs
BrainsGate
Ophthalmology
What sets aCROss apart is the physician-led approach. Having MDs who understand both the science and the operational reality made a real difference in our ophthalmology program across Georgia and Armenia.
CD
Clinical Development Director
European Medical Device Company
Cardiology
As a startup with limited budget, we needed a CRO that could deliver quality without the overhead of a large organization. aCROss Medical gave us exactly that - personal attention, fast timelines, and high-quality data accepted by the FDA for our pivotal trial.
CEO
CEO & Founder
Israeli Pharma Startup
Cell Therapy
aCROss was introduced to us through a mutual connection. From the very beginning of our collaboration, it became clear that this would be more than a typical CRO partnership; it would be a true team effort. We now look forward to continuing this successful collaboration in Phase 3.
YP
Dr. Yael Porat and the BioGenCell team
BioGenCell
ICU
Across Medical was an outstanding partner for PATH EX in executing our human feasibility study outside the United States. Their team demonstrated strong local knowledge, efficient site coordination, and a clear understanding of both clinical and regulatory expectations.
PX
Cofounder & CFO
PATHEX
Read All Testimonials
FAQ

Frequently Asked Questions

Everything our partners ask before starting a study with us.

Why run clinical trials in Georgia, Armenia or Uzbekistan instead of Western Europe?
Running clinical trials in Georgia, Armenia or Uzbekistan offers three major advantages over Western Europe and the US: regulatory approval in 6-8 weeks (vs. 6-8 months), significantly lower operational costs, and access to large treatment-naive patient populations. Data generated in these countries is accepted by the FDA and European authorities, making them ideal for international sponsors looking to accelerate timelines without compromising on quality.
How long does study start-up take with aCROss Medical?
aCROss Medical achieves site initiation within 6-8 weeks from study start - significantly faster than the US or EU. Our established relationships with over 40 dedicated clinical centers and our physician-led team allow us to move quickly from feasibility to first patient in.
What phases of clinical trials does aCROss Medical manage?
aCROss Medical manages clinical trials across all phases - Phase I through Phase IV, including First-in-Human (FIH) studies. Our experience spans medical devices, pharmaceutical trials, (from FIH to pivotal CE mark studies) and advanced therapy medicinal products (ATMPs), including cell and gene therapy.
Is data from Georgia, Armenia, Israel and Uzbekistan accepted by the FDA and European authorities?
Yes. Clinical trial data from all four of our operating countries is accepted by both the FDA and European authorities. Our sites operate in full compliance with ICH-GCP guidelines and our studies have been successfully inspected by international regulatory authorities. Results have been published in The Lancet, JACC, BMJ and other leading journals.
What therapeutic areas does aCROss Medical cover?
aCROss Medical covers cardiology, ophthalmology (glaucoma, retina, cornea and ocular implants), orthopedics, neurology, urology, oncology, infectious disease, respiratory, vascular and general surgery. We also conduct ICU and stem cell studies.
What makes aCROss Medical different from other CROs?
aCROss Medical was founded by former sponsors, which means we approach every study with a sponsor's mindset - not just as a service provider. Our physician-led team of local and international MDs stays personally involved in every study. With 20+ years of experience, 70+ completed trials and a 95% regulatory audit success rate, we combine scientific expertise with operational efficiency to deliver results, not just run trials.

Ready to Start Your Clinical Study?

Choose a faster, more cost-effective path for your trial in Georgia, Armenia, Israel and Uzbekistan.

Get In Touch